• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信号分子如何调控肿瘤微环境:与创伤修复的平行关系。

How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.

机构信息

Department for Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, Inc., 040 11 Košice, Slovakia.

Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia.

出版信息

Molecules. 2017 Oct 26;22(11):1818. doi: 10.3390/molecules22111818.

DOI:10.3390/molecules22111818
PMID:29072623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6150347/
Abstract

It is now suggested that the inhibition of biological programs that are associated with the tumor microenvironment may be critical to the diagnostics, prevention and treatment of cancer. On the other hand, a suitable wound microenvironment would accelerate tissue repair and prevent extensive scar formation. In the present review paper, we define key signaling molecules (growth factors, cytokines, chemokines, and galectins) involved in the formation of the tumor microenvironment that decrease overall survival and increase drug resistance in cancer suffering patients. Additional attention will also be given to show whether targeted modulation of these regulators promote tissue regeneration and wound management. Whole-genome transcriptome profiling, in vitro and animal experiments revealed that interleukin 6, interleukin 8, chemokine (C-X-C motif) ligand 1, galectin-1, and selected proteins of the extracellular matrix (e.g., fibronectin) do have similar regulation during wound healing and tumor growth. Published data demonstrate remarkable similarities between the tumor and wound microenvironments. Therefore, tailor made manipulation of cancer stroma can have important therapeutic consequences. Moreover, better understanding of cancer cell-stroma interaction can help to improve wound healing by supporting granulation tissue formation and process of reepithelization of extensive and chronic wounds as well as prevention of hypertrophic scars and formation of keloids.

摘要

现在有人提出,抑制与肿瘤微环境相关的生物程序可能对癌症的诊断、预防和治疗至关重要。另一方面,合适的创面微环境将加速组织修复并防止广泛的瘢痕形成。在本综述论文中,我们定义了参与肿瘤微环境形成的关键信号分子(生长因子、细胞因子、趋化因子和半乳糖凝集素),这些信号分子会降低癌症患者的总体生存率并增加其耐药性。此外,我们还将关注这些调节剂的靶向调节是否能促进组织再生和创面管理。全基因组转录组谱分析、体外和动物实验表明,白细胞介素 6、白细胞介素 8、趋化因子(C-X-C 基序)配体 1、半乳糖凝集素 1 和细胞外基质中的选定蛋白(例如纤维连接蛋白)在创面愈合和肿瘤生长过程中具有相似的调节作用。已发表的数据表明,肿瘤微环境和创面微环境之间存在显著的相似性。因此,针对肿瘤基质的定制操作可能会产生重要的治疗效果。此外,更好地了解癌细胞-基质相互作用有助于通过支持肉芽组织形成和广泛慢性创面的上皮化过程以及预防增生性瘢痕和瘢痕疙瘩形成来改善创面愈合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/6150347/eb373d9deb57/molecules-22-01818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/6150347/a30406a13c5a/molecules-22-01818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/6150347/eb373d9deb57/molecules-22-01818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/6150347/a30406a13c5a/molecules-22-01818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/6150347/eb373d9deb57/molecules-22-01818-g002.jpg

相似文献

1
How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.信号分子如何调控肿瘤微环境:与创伤修复的平行关系。
Molecules. 2017 Oct 26;22(11):1818. doi: 10.3390/molecules22111818.
2
Galectins as regulators of cell survival in the leukemia niche.半乳糖凝集素作为白血病微环境中细胞存活的调节因子。
Adv Biol Regul. 2019 Jan;71:41-54. doi: 10.1016/j.jbior.2018.09.003. Epub 2018 Sep 12.
3
Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.瘢痕疙瘩与瘢痕:瘢痕疙瘩和瘢痕的综述,包括其发病机制、危险因素及治疗。
Curr Opin Pediatr. 2006 Aug;18(4):396-402. doi: 10.1097/01.mop.0000236389.41462.ef.
4
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.简明综述:CD44在癌症干细胞中的新兴作用:一种有前景的生物标志物和治疗靶点
Stem Cells Transl Med. 2015 Sep;4(9):1033-43. doi: 10.5966/sctm.2015-0048. Epub 2015 Jul 1.
5
The role of TGFβ in wound healing pathologies.TGFβ 在创伤愈合病理中的作用。
Mech Ageing Dev. 2018 Jun;172:51-58. doi: 10.1016/j.mad.2017.11.004. Epub 2017 Nov 11.
6
Progress in corneal wound healing.角膜伤口愈合的进展。
Prog Retin Eye Res. 2015 Nov;49:17-45. doi: 10.1016/j.preteyeres.2015.07.002. Epub 2015 Jul 18.
7
Immunomodulatory Properties of Chitosan: Impact on Wound Healing and Tissue Repair.壳聚糖的免疫调节特性:对创伤愈合和组织修复的影响。
Endocr Metab Immune Disord Drug Targets. 2020;20(10):1611-1623. doi: 10.2174/1871530320666200503054605.
8
[Basic biological roles of galectins in tissue repair and tumor growth].[半乳糖凝集素在组织修复和肿瘤生长中的基本生物学作用]
Cas Lek Cesk. 2014;153(5):231-7.
9
Molecular dissection of abnormal wound healing processes resulting in keloid disease.异常伤口愈合过程的分子剖析导致瘢痕疙瘩病。
Wound Repair Regen. 2010 Mar-Apr;18(2):139-53. doi: 10.1111/j.1524-475X.2009.00553.x. Epub 2009 Dec 11.
10
Microdialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular Profiles.从伤口液体中进行微透析采样可实现对细胞因子、蛋白质和代谢物的定量评估,揭示骨缺损特异性分子图谱。
PLoS One. 2016 Jul 21;11(7):e0159580. doi: 10.1371/journal.pone.0159580. eCollection 2016.

引用本文的文献

1
Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes.2型糖尿病db/db小鼠模型中糖尿病肾病的多组学特征分析
Comput Struct Biotechnol J. 2025 Jul 23;27:3399-3409. doi: 10.1016/j.csbj.2025.07.037. eCollection 2025.
2
Sensory innervation in the prostate and a role for calcitonin gene-related peptide in prostatic epithelial proliferation.前列腺中的感觉神经支配以及降钙素基因相关肽在前列腺上皮增殖中的作用。
Front Mol Neurosci. 2024 Dec 18;17:1497735. doi: 10.3389/fnmol.2024.1497735. eCollection 2024.
3
Partial regression of conventional renal cell carcinoma displays markers of wound repair.

本文引用的文献

1
Advanced Growth Factor Delivery Systems in Wound Management and Skin Regeneration.伤口管理与皮肤再生中的先进生长因子递送系统
Molecules. 2017 Jul 27;22(8):1259. doi: 10.3390/molecules22081259.
2
Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.迁移抑制剂——抗转移和抗侵袭药物:前景与挑战
Trends Cancer. 2017 Jun;3(6):391-406. doi: 10.1016/j.trecan.2017.04.008.
3
Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration.协同的 IL-6 和 IL-8 旁分泌信号通路提示了抑制肿瘤细胞迁移的策略。
传统肾细胞癌的部分消退显示出伤口修复的标志物。
J Clin Pathol. 2025 May 25;78(6):404-408. doi: 10.1136/jcp-2024-209459.
4
Integrins as a bridge between bacteria and cells: key targets for therapeutic wound healing.整合素作为细菌与细胞之间的桥梁:治疗伤口愈合的关键靶点。
Burns Trauma. 2024 Jul 16;12:tkae022. doi: 10.1093/burnst/tkae022. eCollection 2024.
5
Integrins regulation of wound healing processes: insights for chronic skin wound therapeutics.整合素对伤口愈合过程的调控:慢性皮肤伤口治疗的新视角。
Front Cell Infect Microbiol. 2024 Mar 5;14:1324441. doi: 10.3389/fcimb.2024.1324441. eCollection 2024.
6
Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma.微环境成分在头颈部鳞状细胞癌中的作用
J Pers Med. 2023 Nov 17;13(11):1616. doi: 10.3390/jpm13111616.
7
Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: ‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling.解析癌症相关成纤维细胞对乳腺癌 EM-G3 细胞系不良预后标志物的异质性影响:基于转录组谱的靶向治疗(抗 IL-6、抗 VEGF-A、抗 MFGE8)。
Oncol Rep. 2024 Jan;51(1). doi: 10.3892/or.2023.8662. Epub 2023 Nov 17.
8
Heterogeneous response to TGF-β1/3 isoforms in fibroblasts of different origins: implications for wound healing and tumorigenesis.不同来源成纤维细胞对 TGF-β1/3 异构体的异质性反应:对创伤愈合和肿瘤发生的影响。
Histochem Cell Biol. 2023 Dec;160(6):541-554. doi: 10.1007/s00418-023-02221-5. Epub 2023 Sep 14.
9
GEO data mining identifies potential immune-related genes in hypertrophic scar and verities in a rabbit model.GEO数据挖掘识别肥厚性瘢痕中潜在的免疫相关基因及兔模型中的变化。
Heliyon. 2023 Jun 14;9(7):e17266. doi: 10.1016/j.heliyon.2023.e17266. eCollection 2023 Jul.
10
End-stage kidney disease: a never healing wound leading to another never healing wound, renal cancer.终末期肾病:一个永不愈合的伤口,导致另一个永不愈合的伤口,即肾癌。
J Nephrol. 2023 Jul;36(6):1673-1681. doi: 10.1007/s40620-023-01694-w. Epub 2023 Jul 13.
Nat Commun. 2017 May 26;8:15584. doi: 10.1038/ncomms15584.
4
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers.依维莫司联合来曲唑治疗复发性雌激素受体阳性高级别卵巢癌的Ⅱ期临床试验。
Gynecol Oncol. 2017 Jul;146(1):64-68. doi: 10.1016/j.ygyno.2017.04.020. Epub 2017 Apr 28.
5
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies.晚期恶性肿瘤患者伊马替尼联合伊匹单抗的 I 期临床试验。
J Immunother Cancer. 2017 Apr 18;5:35. doi: 10.1186/s40425-017-0238-1. eCollection 2017.
6
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.一项针对人抗血小板衍生生长因子受体α单克隆抗体(olaratumab,IMC-3G3)用于既往接受过治疗的转移性胃肠道间质瘤患者的II期研究。
Ann Oncol. 2017 Mar 1;28(3):541-546. doi: 10.1093/annonc/mdw659.
7
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).CXCR4拮抗剂普乐沙福联合大剂量阿糖胞苷和依托泊苷治疗复发或难治性急性白血病或骨髓增生异常综合征儿童的1期研究:一项儿科肿瘤学实验治疗研究人员联盟研究(POE 10-03)
Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26414. Epub 2017 Apr 14.
8
The role of peroxiredoxins in cancer.过氧化物还原酶在癌症中的作用。
Mol Clin Oncol. 2017 Feb;6(2):139-153. doi: 10.3892/mco.2017.1129. Epub 2017 Jan 10.
9
Preclinical development of a humanized neutralizing antibody targeting HGF.一种靶向肝细胞生长因子的人源化中和抗体的临床前开发
Exp Mol Med. 2017 Mar 24;49(3):e309. doi: 10.1038/emm.2017.21.
10
The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.CXCR4 抑制剂 BL-8040 通过改变 miR-15a/16-1 的表达来下调 ERK、BCL-2、MCL-1 和 cyclin-D1,从而诱导 AML 白血病细胞凋亡。
Leukemia. 2017 Nov;31(11):2336-2346. doi: 10.1038/leu.2017.82. Epub 2017 Mar 10.